Accéder au contenu
Merck

Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism.

Translational psychiatry (2012-09-06)
R A Clarke, S Lee, V Eapen
RÉSUMÉ

Tourette syndrome (TS) is a highly heritable neuropsychiatric disorder characterised by motor and vocal tics. Despite decades of research, the aetiology of TS has remained elusive. Recent successes in gene discovery backed by rapidly advancing genomic technologies have given us new insights into the genetic basis of the disorder, but the growing collection of rare and disparate findings have added confusion and complexity to the attempts to translate these findings into neurobiological mechanisms resulting in symptom genesis. In this review, we explore a previously unrecognised genetic link between TS and a competing series of trans-synaptic complexes (neurexins (NRXNs), neuroligins (NLGNs), leucine-rich repeat transmembrane proteins (LRRTMs), leucine rich repeat neuronals (LRRNs) and cerebellin precursor 2 (CBLN2)) that links it with autism spectrum disorder through neurodevelopmental pathways. The emergent neuropathogenetic model integrates all five genes so far found to be uniquely disrupted in TS into a single pathogenetic chain of events described in context with clinical and research implications.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-IMMP2L antibody produced in rabbit, affinity isolated antibody